[Treatment of chronic blepharokeratoconjunctivitis with local calcineurin inhibitors].
Topical calcineurin inhibitors (cyclosporin A 1%, FK506, pimecrolimus) can be useful for treating chronic blepharokeratoconjunctivitis in addition to lid hygiene and lubricants. This treatment leads to an improvement of dry eye symptoms and reduces inflammation.
Auw-Hädrich
C
C
Universitäts-Augenklinik, Killianstrasse 5, 79106 Freiburg. claudia.auw-haedrich@uniklinik-freiburg.de
Reinhard
T
T
D000287:Administration, Topical; D001762:Blepharitis / Q000188:drug therapy*; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000008:administration & dosage*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007637:Keratoconjunctivitis / Q000188:drug therapy*; D016559:Tacrolimus / Q000008:administration & dosage* / Q000031:analogs & derivatives*
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016572:Cyclosporine; D016559:Tacrolimus